rc 3095 has been researched along with lhrh, lys(6)- in 1 studies
Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (lhrh, lys(6)-) | Trials (lhrh, lys(6)-) | Recent Studies (post-2010) (lhrh, lys(6)-) |
---|---|---|---|---|---|
108 | 2 | 26 | 23 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K | 1 |
1 other study(ies) available for rc 3095 and lhrh, lys(6)-
Article | Year |
---|---|
Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Connective Tissue; ErbB Receptors; Gastrin-Releasing Peptide; Gonadotropin-Releasing Hormone; Male; Mitosis; Peptide Fragments; Peptides; Prostatic Neoplasms; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptor, IGF Type 1; Receptors, Bombesin; Testosterone; Time Factors | 1993 |